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collagenase solution [2 mg/mL type-II collagenase; 5% FCS; 2%
P/S/A; 1% L-glutamine and 0.1 mg/mL DNA I or 150 U/L in RPMI].
The cells were ﬁltered through a nylon ﬁlter with a pore diameter
of 25 μm. Cells were cultured at a density of 5,000 to 10,000
cells/cm2 in culture bottles with a surface area of 25 cm2 or 75
cm2. The culture medium used was RPMI with 10% FCS, 1% P/S
and 1% L-glutamine. After 24 hours of culture, the synoviocytes
were incubated with IB0004, HA-E and HA-F for 12, 24 and 48 h
at the concentration of 1μg/ml, 10μg/ml, 100μg/ml and 200μg/ml
and compared for eHA content in culture supernatant measured
by ELISA (Corgenix Inc., USA). The results are presented as the
mean of the 9 individual experiments carried out in the cultures ±
SD. Statistical analysis was performed using Student’s two-tailed t
test for unpaired data and signiﬁcant when p < 0.05.
Results: Baseline levels of eHA measured in the cell cultures with
no intervention were 469, 614 and 605 ng/ml after 12, 24 and 48
hours, respectively (Table 1). All three interventions (IB0004, HA-E
and HA-F) induced dose dependent increases in eHA at all three
incubation times (12, 24 and 48 hours) compared to basal levels.
The increases in eHA synthesis were not signiﬁcant at the lowest
intervention concentrations of 1 μg/ml and 10 μg/ml, but were
signiﬁcant (p < 0.05) for IB0004, HA-E and HA-F at the two higher
concentrations, 100 μg/ml and 200 μg/ml at hours 12, 24 and
48. There were signiﬁcant differences noted between intervention
groups. After 12 hours, cells cultured with IB0004 produced the
highest levels of eHA at both 100 (41,667 ng/ml) and 200 μg/ml
(90,049 ng/ml). These values were signiﬁcantly higher than the
eHA values for HA-F (p < 0.05). This difference was even more
pronounced after 24 hours of incubation for IB0004 vs HA-E and
IB004 vs HA-F (p < 0.01). After 48 hours, the levels of eHA in
the cultures of the three molecules were less differentiated. At
the concentration of 100 μg/ml, the highest levels of eHA were
still found in the cells cultured with IB0004 (p < 0.05 compared
to HA-F), followed by HA-E and HA-F, but at 200 μg/ml, HA-E
showed the highest eHA stimulation (Table 1).
Table 1. Synoviocytes eHA stimulation levels- baseline and with three interven-
tions (±SD)
All values signiﬁcant Concentration HA (ng/ml)
over baseline (p<0.05) 12 Hours 24 Hours 48 Hours
Baseline (0 ng/ml) 469 (130) 614 (92) 605 (129)
IB0004 (100 ng/ml) 41667 (1361) 82548 (9675) 46258 (7550)
IB0004 (200 ng/ml) 90049 (4159) 132669 (5140) 102715 (9811)
HA-E (100 ng/ml) 26728 (5441) 28745 (4269) 29152 (5195)
HA-E (200 ng/ml) 82936 (3315) 93120 (6653) 127767 (9568)
HA-F (100 ng/ml) 10620 (787) 16747 (1613) 17429 (2027)
HA-F (200 ng/ml) 63528 (10817) 73649 (7794) 87576 (8113)
p<0.05 for
all interventions
Conclusions: This comparative study showed a dose-dependent
effect for all three groups (IB0004, extracted HA and fermented
HA) on endogenous HA synthesis in human synoviocytes, with
the most effective concentrations being 100 μg/ml and 200 μg/ml.
IB0004 was most efﬁcient in inducing eHA synthesis in synovio-
cytes, followed by extracted HA and fermented HA.
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Purpose: In the absence of randomized trials with head-to-head
comparisons of Glucosamine Hydrochloride (GHC) and Special-
ized Rosehip Powder (SRP), we subjected the pain reducing
effect of GHC and SRP therapy for OA to an indirect comparison
meta-analysis.
Methods: From published meta-analyses we know that hetero-
geneity among trials of glucosamine for pain in OA is larger
than would be expected by chance - an inconsistency making
conclusions difﬁcult and differences were shown between various
preparations of glucosamine (Vlad SC, A&R 2007). On the other
hand, a recent meta-analysis of the efﬁcacy associated with the
use of a patented SRP, showed homogeneity (Christensen R, OAC
2008). It is of a large interest to the scientiﬁc community to ﬁnd
indications of effect on pain of such preparations in the available
literature. Randomized controlled trials (RCTs) included in the orig-
inal above mentioned meta-analyses were considered eligible for
inclusion; i.e. only randomized, double-blind, placebo-controlled
trials. The standardized mean difference (SMD) for each study
was applied as effect size. We calculated the I2 index to evaluate
the inconsistency via the percentage of total variation across trials
that is attributable to heterogeneity rather than to chance. We used
standard random-effects meta-analysis as default option (Review
Manager, v. 5.0.18). The estimated difference in efﬁcacy of GHC
and SRP was analyzed using the Bucher approach, leading to an
indirect comparison via the two direct effect sizes.
Results: Three studies included for the GHC analysis (including
933 patients in total) consistently showed no clinical effect (ES=
-0.01 [-0.14, 0.12], P=0.89, I2=0%). Whereas the three studies us-
ing SRP (287 patients in total) showed a consistent and signiﬁcant
clinical improvement compared to placebo (SMD= 0.37 [-0.60,
-0.14], P=0.002, I2=0%). When comparing these two estimates
it was evident that SRP was superior to GHC (SMD=0.36 [0.10,
0.62], Z= 2.67, P=0.008).
Conclusions: Based on available RCTs it was evident that glu-
cosamine hydrochloride had no effect on pain in OA patients com-
pared to placebo. The patented rosehip preparation tested in RCTs
showed a statistical- and clinically-signiﬁcant effect compared to
placebo. We conclude that based on the available evidence from
meta-analyses, an indirect comparison showed the specialized
rosehip powder to be more efﬁcacious than glucosamine hy-
drochloride - reducing pain in osteoarthritis patients.
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Purpose: The purpose of the current study was to compare
the accuracy of 12 maximal strength (1RM) prediction equations
